Loading...
Chemical structure of BMS-983970

GC35537

BMS-983970

Also known as (2S,3R)-2-(cyclopropylmethyl)-N'-[(3S)-9-fluoro-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl]-3-(3,3,3-trifluoropropyl)butanediamide

BMS-983970 is an oral pan-Notch inhibitor for the treatment of multiplecancers

ChemicalCAS1584713-87-0MW518.5FormulaC26H26F4N4O3
CAS number
1584713-87-0
Molecular weight
518.5
Formula
C26H26F4N4O3
Solubility
DMSO： ≥ 50 mg/mL (96·43 mM); Water： ＜ 0·1 mg/mL (insoluble)
InChIKey
RANYIWAZSQWERN-WLENULPWSA-N
Catalogue number
GC35537
Brand
GLPBIO
Computed properties PubChem CID 73388374 · XLogP 4.1 · TPSA 114 Ų · H-bond donors 3
XLogP
4.1
TPSA
114 Ų
H-bond donors
3
H-bond acceptors
8
Rotatable bonds
9
Heavy atoms
37

SMILES C1CC1C[C@@H]([C@@H](CCC(F)(F)F)C(=O)N[C@@H]2C(=O)NC3=C(C=CC=C3F)C(=N2)C4=CC=CC=C4)C(=O)N

Computed descriptors from PubChem (CID 73388374), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.